1-20 of 140
Subject: Genitourinary Cancer
Sort by
Journal Article
Inferred clonal hematopoiesis from tumor DNA sequencing among men with prostate cancer: correlation with somatic tumor alterations and outcomes
Yasaman Iranmanesh and others
The Oncologist, Volume 30, Issue 4, April 2025, oyaf049, https://doi.org/10.1093/oncolo/oyaf049
Published: 22 April 2025
Journal Article
Clinical and pathological outcomes of deferred nephrectomy in patients with metastatic and locally advanced RCC after immune checkpoint inhibitors
Paulo S do Amaral and others
The Oncologist, Volume 30, Issue 4, April 2025, oyaf004, https://doi.org/10.1093/oncolo/oyaf004
Published: 04 April 2025
Journal Article
“Incidentally” discovered Von Hippel Lindau disease: an emerging clinical phenotype
Michael N Trinh and others
The Oncologist, Volume 30, Issue 3, March 2025, oyaf015, https://doi.org/10.1093/oncolo/oyaf015
Published: 10 March 2025
Journal Article
Response to pembrolizumab in advanced prostate cancer with predictive biomarkers
Nicole J Altomare and others
The Oncologist, Volume 30, Issue 3, March 2025, oyaf025, https://doi.org/10.1093/oncolo/oyaf025
Published: 10 March 2025
Journal Article
Differentiating between renal medullary and clear cell renal carcinoma with a machine learning radiomics approach
Rahim Jiwani and others
The Oncologist, Volume 30, Issue 2, February 2025, oyae337, https://doi.org/10.1093/oncolo/oyae337
Published: 18 February 2025
Journal Article
Updated overall survival in patients with prior checkpoint inhibitor therapy in the phase III TIVO-3 study
Miguel Zugman and others
The Oncologist, Volume 30, Issue 2, February 2025, oyae369, https://doi.org/10.1093/oncolo/oyae369
Published: 06 February 2025
Journal Article
A first-in-human study of JNJ-70218902, a bispecific T-cell-redirecting antibody against TMEFF2 in metastatic castration-resistant prostate cancer
Emiliano Calvo and others
The Oncologist, Volume 30, Issue 1, January 2025, oyae313, https://doi.org/10.1093/oncolo/oyae313
Published: 20 January 2025
Journal Article
Feasibility and acceptability of a mindfulness app-based intervention among patients with metastatic renal cell carcinoma: a multinational study
Cristiane Decat Bergerot and others
The Oncologist, Volume 30, Issue 1, January 2025, oyae309, https://doi.org/10.1093/oncolo/oyae309
Published: 17 January 2025
Journal Article
Racial differences in real-world outcomes of first-line therapies for advanced renal cell carcinoma
Daniel M Geynisman and others
The Oncologist, oyae354, https://doi.org/10.1093/oncolo/oyae354
Published: 19 December 2024
Journal Article
Systematic literature review and meta-analysis of health state utility values in metastatic castration-resistant prostate cancer
Elena Castro and others
The Oncologist, oyae321, https://doi.org/10.1093/oncolo/oyae321
Published: 26 November 2024
Journal Article
Leptin levels are associated with coronary artery calcification in patients with advanced prostate cancer
Efstratios Koutroumpakis and others
The Oncologist, oyae308, https://doi.org/10.1093/oncolo/oyae308
Published: 18 November 2024
Journal Article
Functional assessment in patients with castration-resistant prostate cancer treated with darolutamide: results from the DaroAcT study
Tomasz M Beer and others
The Oncologist, oyae287, https://doi.org/10.1093/oncolo/oyae287
Published: 25 October 2024
Journal Article
Comparative efficacy and safety of talazoparib plus enzalutamide and other first-line treatments for metastatic castration-resistant prostate cancer
Elena Castro and others
The Oncologist, Volume 30, Issue 3, March 2025, oyae237, https://doi.org/10.1093/oncolo/oyae237
Published: 19 October 2024
Journal Article
Phase Ib study of anti-PD-L1 monoclonal antibody socazolimab in combination with nab-paclitaxel as first-line therapy for advanced urothelial carcinoma
Bixia Tang and others
The Oncologist, Volume 30, Issue 2, February 2025, oyae260, https://doi.org/10.1093/oncolo/oyae260
Published: 17 October 2024
Journal Article
Emerging innovative treatment strategies for advanced clear cell renal cell carcinoma
Sharon H Choi and others
The Oncologist, Volume 30, Issue 3, March 2025, oyae276, https://doi.org/10.1093/oncolo/oyae276
Published: 14 October 2024
Journal Article
Meta-analysis of platinum chemotherapy combinations with immunotherapy in metastatic urothelial carcinoma
Hatice Bolek and others
The Oncologist, Volume 29, Issue 11, November 2024, Pages 999–1002, https://doi.org/10.1093/oncolo/oyae243
Published: 28 September 2024
Journal Article
Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study
Fernando Sabino Marques Monteiro and others
The Oncologist, Volume 30, Issue 2, February 2025, oyae220, https://doi.org/10.1093/oncolo/oyae220
Published: 02 September 2024
Journal Article
Liquid biopsy in renal cell carcinoma
Marc Machaalani and others
The Oncologist, Volume 29, Issue 10, October 2024, Pages 821–823, https://doi.org/10.1093/oncolo/oyae230
Published: 26 August 2024
Journal Article
Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma
Tian Zhang and others
The Oncologist, Volume 29, Issue 12, December 2024, Pages 1003–1013, https://doi.org/10.1093/oncolo/oyae215
Published: 21 August 2024
Journal Article
High sensitivity ctDNA assays in genitourinary malignancies: current evidence and future directions
Kartik R Patel and others
The Oncologist, Volume 29, Issue 9, September 2024, Pages 731–737, https://doi.org/10.1093/oncolo/oyae198
Published: 02 August 2024
Advertisement
Advertisement